|
|
|
12/22/99 12/8/99 11/29/99 11/26/99 Freeze Frame
Microscope Could Demystify Cancer IRVINE, Calif.---The first microscope that can penetrate the mysteries of living human cells has been built by University of California-Irvine researchers, with the possibility it will eventually change the way diseases like cancer are diagnosed and treated. The technology uses shock waves produced by laser beams to capture, freeze, and chemically analyze the contents of a cell. The ability to surprise a cell before it has time to change its internal chemistry in defense is a key factor to learning how diseased cells behave, and what types of drugs might treat them best. "We've had so much interest in what we're doing that we're going to try to accelerate the program," said Dr. Michael Berns, director of the Beckman Laser institute at UCI, which received $2.2 million from the National Institutes of Health last month. The grant will be used to develop a miniaturized commercial prototype of the microscope over the next few years. Researchers hope that eventually hospitals and medical labs will use the technology to study the chemistry inside the living cells of sick people in the same way that blood tests are given today. "(Berns) is proposing a major breakthrough in our capacity to understand what happens in diseased cells," said Dr. Michael Morron, director of biomedical technology for the National Center for Research Resources. "The hope is to try to distinguish what makes cancer cells go bad." The idea started two years ago with Dr. Nancy Allbritton, a UCI medical researcher studying how cancer cells behave. Like many scientists, Allbritton was frustrated with her inability to study the internal processes of cells, which are the building blocks of the human body. Cancer begins when normal cells start reproducing wildly. No one knows why they do this, but researchers like Allbritton hope that learning what triggeers this erratic behavior in a cell can teach them how to turn it off. Today, the most common way of analyzing cellular chemistry is to take millions of cells, put them in a blender, and then study the chemicals that are left. But this doesn't tell scientists how living cells actually perform. The difficulty is that cells are so small: a billionth of a millimeter in size. [Actually cells are much bigger than that....more like a hundredth of a millimeter in size.--D.F.] Each is surrounded by a plasma membrane; inside are tens of thousands of molecules, each with their own chemistry. Scientists have figured out how to get inside that plasma membrane---using detergent to dissolve it, for example---but not without dramatically altering the cell's composition. "It's pretty difficult to analyze a very tiny speck that you can barely see under the microscope and figure out how all these tens of thousands of molecules are interacting with each other," said Bruce Tromberg, director of Beckman's biotechnology resource center. "But those cells are determining how long you are going to live and how you are going to fight disease." At lunch in 1997, Allbritton confided her frustration to Tromberg. He responded that laser techology at the Beckman Institute could probably help. Within months, the pair had come up with a system that uses focused bursts of light to expode a cell within 30 milliseconds --- so fast that it doesn't have time to react defensively. Then, the chemical contents of the cell are transferred into a micropipette ---a glass tube ---where its molecules are electrically sorted and measured by computer. "The cell is alive until the moment we do this," Allbritton said. "We do it so fast, we freeze all the reactions." After the success of the technology, UCI applied for a patent and for a federal grant to expand its capabilities. Now, the college wants to share. If Berns and his team of scientists working jointly from several UCI departments succeed in their goal of building a miniature computer microchip with the laser information embedded in it, it could be developed by a manufacturing company and marketed world-wide. Most immediately, Allbritton, her husband, Chris Sims, who is also a member of the team, and four others are studying how tumor cells react while working on a version of the miscoscope that can be placed on a device only a few inches square. "The idea is to develop systems to fit onto a small glass or plastic device that is easily transportable," Sims said. "Then, everybody could have it in their lab to analyze cells." 11/10/99: 9/20/99: 9/2/99: 7/26/99: 6/21/99:
It is with deep sadness that we report Ernie's death on May 17 from glioblastoma. Ernie was able to keep his research program going quite productively until his death. The lab is continuing the research, some of it under the mentorship of new Searle Scholar, Catherine Dulac, whose lab is nearest neighbor to Ernie's. Lily Jan and David Julius and James Lechleiter wrote the following testimonial for the Searle website: With a long-standing interest in determining how muscarinic acetylcholine receptors modulate cardiac and smooth muscle function, exocrine secretion, and central neuronal activities important for learning and memory, Dr. Ernie Peralta pioneered the molecular studies that led the field into fascinating and uncharted territories. By his own account, Ernie was a reductionist whose approach to understanding a biological signaling pathway involved first identifying key molecular components of the system through gene cloning methods. These molecules were elegantly manipulated in "simple" heterologous expression systems with the aim of understanding how they interact to regulate interesting and fundamental physiological processes, such as neurotransmitter release at the synapse or pacemaker activity in the heart. As a postdoctoral fellow at Genentech, Ernie helped to usher in a new and exciting era of molecular pharmacology by isolating cDNA clones encoding muscarinic acetylcholine receptors. Indeed, this work represents one of the earliest success stories in identifying a gene encoding a G protein-coupled receptor and examining its properties in heterologous expression systems. Ernie made great use of these clones by demonstrating that a single transmitter or hormone can modulate different second messenger signaling pathways, and that specificity is determined by the complement of receptor and G protein subtypes that a cell expresses. While this may seem obvious from today's perspective, Ernie's studies were among the first to establish a logical molecular framework for understanding how G protein-coupled receptors "talk" to specific G proteins and route their signals to a given second messenger signaling pathway. Ernie's molecular analyses of the cloned muscarinic receptors revealed that inhibitory acetylcholine actions are mediated by the m2 and m4 receptors coupled to pertussis toxin-sensitive G proteins, whereas excitatory actions are mediated by m1, m3 and m5 receptors coupled to Gq/11 proteins and the phospholipase C pathway. Following molecular characterization of the muscarinic acetylcholine receptors, Ernie's group went on to examine mechanisms underlying the inhibitory as well as the excitatory pathways. Their novel findings concerning the inhibitory pathways include molecular analysis of muscarinic potassium channel activation by the G protein beta-gamma subunits and biochemical studies of the function of the regulators of G protein signaling (RGS). In both cases, the studies were original and highly influential. Of equal and perhaps even greater impact were the many discoveries of Ernie's group regarding mechanisms mediating the excitatory pathways. The unexpected finding of tyrosine kinase-mediated Kv1.2 potassium channel suppression by m1 receptor in neuroblastoma-glioma cells as well as expression systems received wide attention, pointing to connections between signaling pathways previously thought to be separate. Characteristic of Ernie's insightful and rigorous scientific style, his group pursued the underlying mechanisms to reveal a number of surprises. The uncovered novel effects of m1 receptor activation include ligand-independent EGF receptor activation, Pyk2 tyrosine kinase stimulation, Kv1.2 channel regulation via physical association with the small GTPase RhoA, and tyrosine phosphorylation-dependent association between the channel and receptor tyrosine phosphatase which in turn terminates channel suppression by m1 receptor. In addition to the truly original and valuable leads that these studies have provided to the signaling field, the specific findings on m1 modulation of Kv1.2 channels will have major impact on our understanding of central nervous system functions. The Kv1.2 potassium channels are abundantly expressed in the mammalian brain. The m1 muscarinic acetylcholine receptor is known to increase neuronal excitability by inhibiting a number of potassium channels including the M channel. Despite intense interest and intensive studies for decades, however, how these various potassium channels in central neurons are modulated by acetylcholine remains unknown. The new paradigms established by studies of Peralta's group will provide important guides to future studies. Ernie will be remembered as much for his open and gentle demeanor as for his substantial scientific achievements. Indeed, his personal and professional style to science was exemplary and he provided a heartening glimpse into what constructive and conscientious scientists can accomplish. He unselfishly shared his ideas with us and he gently critiqued ours. His help was without obligation. He created a laboratory environment that was both nurturing and supportive, and yet remained competitive and exciting. It was a wonderful place for a scientist to learn and grow. In his shortened career, Ernie mentored and trained many scientists. He remained active and intimately involved with their careers until his untimely death. Ernie touched many of our lives. He was at once generous, inquisitive, insightful and helpful. Although these combined qualities are rare, Ernie showed us that they are not in conflict with success and fulfillment in the too frequently competitive and aggressive world of biomedical research. Ernie's warmth and bright presence in our community will be deeply missed by all of us, but his scientific and personnel legacy will remain as a wonderful source of strength and inspiration. Lily Jan
6/16/99: 5/11/99: 4/15/99: 3/22/99: CHICAGO, ILLINOIS - Fifteen individuals doing research in the chemical and biological sciences will each have an additional $180,000 to support their research programs during the next three years. The fifteen have been named as the 1999 Searle Scholars. With the names announced today, 318 Searle Scholars have shared over $55,080,000 in grants made since the program began in 1981. This year, 167 applications were considered from recently appointed assistant professors, nominated by 94 universities and research institutions. The final selection of Scholars was based on recommendations made by a committee of eleven scientists distinguished for their research and leadership in the scientific fields of interest to the Searle Scholars Program. In selecting the Scholars, the committee looked for individuals who have already demonstrated innovative research and who have given evidence of having the potential to make significant contributions to biological research over an extended period of time. The funds that support the awards come from trusts established under the wills of John G. and Frances C. Searle. Mr. Searle was President of G.D. Searle & Co., of Skokie, Illinois, a research-based pharmaceutical company. Mr. and Mrs. Searle expressed the wish that some of the proceeds of their estates be used for the support of research in medicine, chemistry, and biological science. In 1980, members of the Searle family acting as Consultants to the Trustees of the Trusts established under the wills of Mr. & Mrs. John G. Searle, recommended the development of a program of support for young biomedical scientists. This idea evolved into the Searle Scholars Program, which is funded through grants from the family trusts to The Chicago Community Trust and administered by Kinship Foundation in Northbrook, Illinois. 1999 Searle Scholars Class (more info...) Carrolee Barlow
Brendan P.
Cormack Kevin H.
Gardner Rachel Green Phyllis I.
Hanson Pehr A.B.
Harbury Jin Jiang Ka Yee C. Lee Karolin Luger William W.
Metcalf Dale A. Ramsden
Pamela L.
Schwartzberg Yigong Shi Frederic E.
Theunissen Ding Xue # # # 3/22/99: 2/4/99: 1/20/99: |
|||||||||||||||||||||||||||||
| SCHOLAR NETWORK | NEWS | EVENTS | APPLY | PROGRAM HISTORY | CONTACT | HOME |
Questions about/problems with this site? Please e-mail the webmaster. © Copyright 2007 Kinship Foundation. All rights reserved. |